Pharmaceutical Executive-06-07-2006

Pharmaceutical Executive

June 06, 2006

Small molecules are an increasingly viable option for cancer therapeutics

Pharmaceutical Executive

June 06, 2006

Increased demand for plant-based hormones has spurred Wyeth to ask FDA to set marketing limits on compounded therapies

Pharmaceutical Executive

June 06, 2006

Medicare Part D has increased drug sales and payers are still trying to hold down costs.